1. Home
  2. GVH vs VIVS Comparison

GVH vs VIVS Comparison

Compare GVH & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globavend Holdings Limited

GVH

Globavend Holdings Limited

HOLD

Current Price

$0.92

Market Cap

2.4M

Sector

N/A

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

SELL

Current Price

$0.26

Market Cap

2.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GVH
VIVS
Founded
2016
2007
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.1M
IPO Year
2023
2010

Fundamental Metrics

Financial Performance
Metric
GVH
VIVS
Price
$0.92
$0.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.2K
★ 26.5M
Earning Date
07-14-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $4,603,000.00
Revenue This Year
$1.85
$228,144.28
Revenue Next Year
N/A
N/A
P/E Ratio
$0.74
★ N/A
Revenue Growth
N/A
★ 8.82
52 Week Low
$0.76
$0.12
52 Week High
$6.46
$3.40

Technical Indicators

Market Signals
Indicator
GVH
VIVS
Relative Strength Index (RSI) 43.35 68.07
Support Level $0.78 $0.22
Resistance Level $1.11 $0.30
Average True Range (ATR) 0.08 0.04
MACD 0.00 0.02
Stochastic Oscillator 26.53 54.17

Price Performance

Historical Comparison
GVH
VIVS

About GVH Globavend Holdings Limited

Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

Share on Social Networks: